Multiple paradoxical adverse events in a patient with ankylosing spondylitis treated with adalimumab

被引：0
|
作者：
Éric Toussirot
Romain Charollais
François Aubin
机构：
[1] University Hospital of Besançon,Clinical Investigation Centre in Biotherapy, INSERM CIC
[2] University Hospital of Besançon,1431
[3] University Hospital of Besançon,FHU INCREASE
[4] University of Franche-Comté,Department of Rheumatology
[5] University Hospital of Besançon,Department of Therapeutics and UPRES EA 4266: “Pathogenic agents and Inflammation”
[6] University of Franche-Comté,Department of Dermatology
来源：
European Journal of Dermatology | 2016年 / 26卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：406 / 408
页数：2
相关论文
共 50 条
  • [21] Multiple sclerosis during adalimumab treatment in a case with ankylosing spondylitis
    Uğur Uygunoğlu
    Derya Uluduz
    Koray Taşçılar
    Sabahattin Saip
    Rheumatology International, 2014, 34 : 141 - 143
  • [22] Multiple sclerosis during adalimumab treatment in a case with ankylosing spondylitis
    Uygunoglu, Ugur
    Uluduz, Derya
    Tascilar, Koray
    Saip, Sabahattin
    RHEUMATOLOGY INTERNATIONAL, 2014, 34 (01) : 141 - 143
  • [23] Reactive Arthritis Triggered by Adalimumab and Leflunomide in a Patient with Ankylosing Spondylitis
    Liu, Ying
    He, Jia
    Jiang, Jingjing
    Wang, Yujuan
    Liu, Ting
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2022, 15 : 2601 - 2605
  • [24] Efficacy and safety of adalimumab in a patient with ankylosing spondylitis on peritoneal dialysis
    Senol Kobak
    Rheumatology International, 2012, 32 : 1785 - 1787
  • [25] Adverse events in patients with ankylosing spondylitis treated with TNF inhibitors: a cross-sectional study
    Jakub Wroński
    Piotr Fiedor
    Piotr Głuszko
    International Journal of Clinical Pharmacy, 2019, 41 : 864 - 871
  • [26] Adverse events in patients with ankylosing spondylitis treated with TNF inhibitors: a cross-sectional study
    Wronski, Jakub
    Fiedor, Piotr
    Gluszko, Piotr
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (04) : 864 - 871
  • [27] Predictors of Radiographic Progression in Adalimumab-Treated Patients with Ankylosing Spondylitis
    Maksymowych, Walter
    Van der Heijde, Desiree
    Landewe, Robert
    Pangan, Aileen
    Brown, L.
    Lavie, Frederic
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (06) : 1161 - 1162
  • [28] Psychotic Depression Induced by Adalimumab in a Patient with Ankylosing Spondylitis: A Case Report
    Erbay, Lale Gonenir
    Sarioglu, Fatma Kartal
    Darilmaz, Cengiz
    Kartalci, Sukru
    PSYCHIATRY AND BEHAVIORAL SCIENCES, 2018, 8 (04): : 204 - 207
  • [29] An Overview of Adalimumab Therapy for Ankylosing Spondylitis
    Sukhanova, Anna M.
    Gilavian, Mariam A.
    Melnik, Elizaveta V.
    Shikh, Evgenia V.
    Petukhov, Alexey E.
    Gegechkori, Vladimir I.
    Dementev, Sergey P.
    Vlasov, Alexander M.
    Ramenskaya, Galina V.
    CURRENT RHEUMATOLOGY REVIEWS, 2024, 20 (05) : 501 - 513
  • [30] Developing multiple sclerosis in an ankylosing spondylitis patient
    Cetiz, A.
    Tasdemir, S.
    Akgun, H.
    Hamcan, S.
    Yucel, M.
    Ulas, U.
    Demirkaya, S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E320 - E320
12345